Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE POTENTIATION OF RESPONSES TO ADRENERGIC NERVE STIMULATION IN THE PRESENCE OF COCAINE: ITS RELATIONSHIP TO THE METABOLIC FATE OF RELEASED NOREPINEPHRINE

S. Z. Langer and María A. Enero
Journal of Pharmacology and Experimental Therapeutics December 1974, 191 (3) 431-443;
S. Z. Langer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María A. Enero
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Responses of the nerve-muscle preparation of the isolated medial muscle of the cat nictitating membrane were determined to nerve stimulation and to exogenous norepinephrine. Cocaine, 0.9 x 10-6 M, induced a shift to the left and an increase in the maximum of the frequency-response curve to nerve stimulation. The responses to nerve stimulation were not affected when monoamine oxidase was inhibited by pretreatment with pargyline or when catechol-O-methyltransferase was inhibited by exposure to U-0521 (3,4-dihydroxy-α-methylpropiophenone). The responses to nerve stimulation remained unchanged when both metabolizing enzymes were simultaneously inhibited. Similar results were obtained for exogenous norepinephrine with the exception of pretreatment with pargyline which induced a small shift to the left in the dose-response curve to norepinephrine. In the medial muscle of the nictitating membrane labeled with 3H-norepinephrine (3H-NE), the deaminated glycol, 3,4-dihydroxyphenylglycol (3H-DOPEG), was the main metabolite in the spontaneous outflow. Unmetabolized 3H-NE represented only 23.3 ± 1.6% of the total increase in radioactivity elicited by nerve stimulation while 3H-DOPEG accounted for 48.2 ± 2.7%. Exposure to cocaine, 0.9 x 10-6 M, did not increase transmitter overflow, but modified the metabolism of 3H-NE released by stimulation. In the presence of cocaine, the 3H-NE fraction increased to 44.1 ± 2.2% of the total overflow whereas the contribution of 3H-DOPEG was reduced to 7.0 ± 1.0%. These results indicate that 3H-DOPEG formation from 3H-NE released by nerve stimulation resulted from the presynaptic metabolism by monoamine oxidase and aldehyde reductase of the released transmitter which was recaptured by adrenergic nerve endings. Potentiation of responses to nerve stimulation in the presence of cocaine appears to be mainly due to an increase in the proportion of the released transmitter which is not metabolized and which therefore reaches the adrenergic receptors of the effector organ.

Footnotes

    • Received January 8, 1974.
    • Accepted July 23, 1974.
  • © 1974 by The Williams & Wilkins Co.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 191, Issue 3
1 Dec 1974
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE POTENTIATION OF RESPONSES TO ADRENERGIC NERVE STIMULATION IN THE PRESENCE OF COCAINE: ITS RELATIONSHIP TO THE METABOLIC FATE OF RELEASED NOREPINEPHRINE
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE POTENTIATION OF RESPONSES TO ADRENERGIC NERVE STIMULATION IN THE PRESENCE OF COCAINE: ITS RELATIONSHIP TO THE METABOLIC FATE OF RELEASED NOREPINEPHRINE

S. Z. Langer and María A. Enero
Journal of Pharmacology and Experimental Therapeutics December 1, 1974, 191 (3) 431-443;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

THE POTENTIATION OF RESPONSES TO ADRENERGIC NERVE STIMULATION IN THE PRESENCE OF COCAINE: ITS RELATIONSHIP TO THE METABOLIC FATE OF RELEASED NOREPINEPHRINE

S. Z. Langer and María A. Enero
Journal of Pharmacology and Experimental Therapeutics December 1, 1974, 191 (3) 431-443;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism
  • Response-Rate Suppression in Operant Paradigm as Predictor of Soporific Potency in Rats and Identification of Three Novel Sedative-Hypnotic Neuroactive Steroids
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics